RWA
VRTX icon

Redmont Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Redmont Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$6.8K Hold
15
– – 0.01% 215
2025
Q3 		$5.88K Hold
15
– – 0.01% 241
2025
Q2 		$6.68K Buy
+15
New +$6.91K 0.01% 221
2024
Q4 		– Sell
-15
Closed -$6.98K – 303
2024
Q3 		$6.98K Hold
15
– – 0.01% 213
2024
Q2 		$7.03K Hold
15
– – 0.01% 215
2024
Q1 		$6.27K Buy
+15
New +$6.34K 0.01% 227

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Redmont Wealth Advisors's VRTX Position: Q4 2025 in Review

Redmont Wealth Advisors held its Vertex Pharmaceuticals (VRTX) position steady in Q4 2025 at 15 shares worth $6.8K. The position accounts for 0.01% of the portfolio, ranked #215.

Redmont Wealth Advisors first reported a position in VRTX in Q1 2024 and has held it in 6 quarters since. The position peaked at $7.03K in Q2 2024. 1,670 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.

  • Redmont Wealth Advisors held 15 shares of Vertex Pharmaceuticals worth $6.8K as of Q4 2025.
  • Redmont Wealth Advisors left its Vertex Pharmaceuticals share count unchanged in Q4 2025.
  • Vertex Pharmaceuticals made up 0.01% of Redmont Wealth Advisors's portfolio in Q4 2025, its #215 holding.
  • Redmont Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 6 quarters since.
  • Redmont Wealth Advisors's Vertex Pharmaceuticals position peaked at $7.03K in Q2 2024.
  • 1,670 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.

Based on Redmont Wealth Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.